AMPHERA B V has a total of 12 patent applications. It decreased the IP activity by 80.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and biotechnology are BRAVOVAX CO LTD, FUNDACAO BUTANTAN and HOOKIPA BIOTECH AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Republic of Korea | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Aerts Joan Geertrudis Jacobus Victor | 10 |
#2 | Hegmans Josephus Petrus Johannes Jacobus | 7 |
#3 | Aerts Joan Gertrudis Jacobus Victor | 2 |
Publication | Filing date | Title |
---|---|---|
KR20190091299A | Pharmaceutical compositions for use in the treatment of cancer | |
EP2938354A1 | Method for preparing an immunogenic lysate, the lysate obtained, dendritic cells loaded with such lysate and a pharmaceutical composition comprising the lysate or the dendritic cells |